Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01303757 · ClinicalTrials.gov registry record · NA

A Novel Diet-Phenotype Interaction Affecting Body Weight

A NA study, sponsored by Boston Children's Hospital.

Completed
Registry status
NA
Development phase
155
Enrollment target

NCT01303757: Completed NA study, sponsored by Boston Children's Hospital.

NCT01303757 is a NA study that has completed, run by Boston Children's Hospital. The registered enrollment target is 155 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01303757, a NA study, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
NA
Development phase
155 participants
Enrollment target

Study Summary

The primary aim of the study is to examine insulin secretion as an effect modifier of the efficacy of a low-fat vs. low-glycemic load diet for weight loss among overweight/obese young adults in an 18-month, prospectively stratified, multi-center randomized controlled trial.

Interventions

  • BEHAVIORAL Dietary counselling

Trial Details

FieldValue
Enrollment Target 155 participants
Start Date 2011-02
Est. Completion 2015-12
Phase NA
Boston Children's Hospital

462 total trials

What the finished NCT01303757 record still lists

NCT01303757 is an interventional study that assigns participants to a tested intervention. The registered 155 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Dietary counselling is the first listed.

NCT01303757 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01303757 about?

NCT01303757 is a clinical study titled "A Novel Diet-Phenotype Interaction Affecting Body Weight". The primary aim of the study is to examine insulin secretion as an effect modifier of the efficacy of a low-fat vs. low-glycemic load diet for weight loss among overweight/obese young adults in an 18-month, prospectively stratified, multi-center randomized controlled trial.

What is the current status of trial NCT01303757?

This trial is currently completed. It is a NA study. The enrollment target is 155 participants. The study started on 2011-02. Estimated completion is 2015-12.

What interventions are being tested in trial NCT01303757?

The interventions under investigation include: Dietary counselling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01303757?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01303757's enrollment target sits among peer trials

155 656th of 2000 higher than 1,345 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03223610 · 155 participants · Phase 1

    Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma

  • NCT05072483 · 155 participants

    Natural History Study of CADASIL

  • NCT05086497 · 155 participants · NA

    WBSI Guided Personalized Delivery of TTFields

  • NCT05412069 · 155 participants · NA

    Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01303757, the US trial registry maintained by the National Library of Medicine. NCT01303757 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.